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Abstract
Background: The neurotrophin nerve growth factor (NGF) is produced by different cell types in
the anterior and posterior eye, exerting a neuroprotective role in the adult life. The visual system
is highly sensitive to NGF and the retina and optic nerve provides suitable subjects for the study of
central nervous system degeneration. The model of bilateral carotid occlusion (two-vessel
occlusion, 2VO) is a well-established model for chronic brain hypoperfusion leading to brain
capillary pathology, to retina and optic nerve degeneration. In order to study if a single intravitreal
injection of NGF protects the retina and the optic nerve from degeneration during systemic
circulatory diseases, we investigated morphological and molecular changes occurring in the retina
and optic nerve of adult rats at different time-points (8, 30 and 75 days) after bilateral carotid
occlusion.
Results: We demonstrated that a single intravitreal injection of NGF (5 μg/3 μl performed 24
hours after 2VO ligation) has a long-lasting protective effect on retina and optic nerve
degeneration. NGF counteracts retinal ganglion cells degeneration by early affecting Bax/Bcl-2
balance- and c-jun- expression (at 8 days after 2VO). A single intravitreal NGF injection regulates
the demyelination/remyelination balance after ischemic injury in the optic nerve toward
remyelination (at 75 days after 2VO), as indicated by the MBP expression regulation, thus
preventing optic nerve atrophy and ganglion cells degeneration. At 8 days, NGF does not modify
2VO-induced alteration in VEFG and related receptors mRNA expression.
Conclusion: The protective effect of exogenous NGF during this systemic circulatory disease
seems to occur also by strengthening the effect of endogenous NGF, the synthesis of which is
increased by vascular defect and also by the mechanical lesion associated with NGF or even vehicle
intraocular delivery.
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Background
Nerve growth factor (NGF) is the best-known member of
a family of neurotrophins (NTs) that regulate neuronal
survival also during adult life [1]. Signals mediated by
NGF are propagated by the high affinity receptor tyrosine
kinase A (TrkA) and the low-affinity receptor p75, which
is a member of the tumor necrosis factor receptor super-
family [2]. NGF plays key roles in the visual system devel-
opment and function. Under normal conditions, NGF
and TrkA are expressed in the anterior segment of the eye
(iris, ciliary body, lens, cornea and conjunctiva), and NGF
is released into the aqueous humour [3]. In the retina,
NGF is produced and utilized by retinal ganglion cells
(RGCs), bipolar neurons as well as glial cells, in a local
paracrine/autocrine fashion. During visual system devel-
opment, NGF, TrkA and p75, as well as other NTs and
their related receptors, are highly expressed in numerous
visual centers, from the retina to the visual cortex, where
NGF influences neuritis outgrowth, survival and selective
apoptosis [4,5]. A retrograde/anterograde transport along
the axons of the RGCs and geniculate nucleus has been
also reported [3]. Moreover, NGF exerts neurotrophic
effects in vascular and capillary pathologies of the eye, as
suggested in experimental diabetes [6] and after ischemia
and reperfusion [7], such as in RGCs degeneration due to
optic nerve section [8].
Models of retinal degeneration have been used to study
changes in gene expression and protein synthesis preced-
ing cell death [9]. In this study, we intended to verify if a
single intravitreal injection of NGF protected the retina
and optic nerve exposed to reduced blood supply. We
tested this hypothesis in rats after bilateral occlusion of
carotid arteries (two-vessel occlusion, 2VO). This is a well-
established model for chronic brain hypoperfusion lead-




3-Month old male Sprague-Dawley rats (Charles River
laboratories Italia, Calco, Lecco) were used for this study.
The animals were housed in polypropylene cages, 4 ani-
mals per cage, under standard light/dark conditions
(lights on 7:00, off 19:00) with food pellets and water ad
libitum. Chronic cerebral hypoperfusion was induced by
permanent bilateral occlusion of the common carotid
arteries [8,9], with sham-operated animals serving as con-
trols. Prior to surgery, the animals were anesthetized with
ketamine hydrochloride (100 mg/kg ip). The common
carotid arteries were exposed via a ventral midline inci-
sion, carefully separated from their sheaths and vagus
nerves, and permanently doubly ligated with 5/0 silk
suture approximately 8 to 10 mm below the origin of the
external carotid artery. The incision was then sutured. The
same procedure, except for artery ligation, was performed
on the sham group. The mortally rate during or immedi-
ately after surgery was 12%. Twenty-four hours post sur-
gery, intravitreal injection of saline (3 μl) or NGF solution
(NGF, 5 μg/3 μl; NGF was generously supplied by Dr.
Luigi Aloe, Institute for Neurobiology and Molecular
Medicine, CNR, Roma, Italy; see Bocchini and Angeletti
1969 [11]) was performed in deeply anaesthetized rats,
using a 25 μl Hamilton syringe with a 27-gauge needle
through the pars plana at the temporal side of the eye
[12]. The classical transcleral approach with the tip of a
microsyringe tangentially inserted through a local sclerot-
omy was used [13]. Injections were performed slowly over
a period of 2 minutes. In the case of intraocular bleeding,
the animal was excluded from the study. As the estimated
volume of the vitreous humor was about 60 μl [14], a 20-
fold dilution of NGF was calculated. Therefore, the actual
concentration of NGF delivered to the retina was 80 μg/
ml.
Three different survival times (8, 30 and 75 days) after sur-
gery were investigated for the purpose of morphological
and morphometric studies, whereas mRNAs expression
was investigated 8 days after ligation. In this experiment,
we observed a 62% loss of pupillary reflex, thus of effec-
tiveness of ligation. The loss of pupillary reflex could be
both bilateral and unilateral [9]. For this reason, only the
eye having lost the pupillary reflex was included in the
study. Experimental groups were composed as shown in
Table 1.
All animal protocols described herein were carried out
according to the European Community Council Direc-
tives of 24 November 1986 (86/609/EEC) and approved
by our intramural committee and the Italian Health Min-
Table 1: Number of eyes included in study in the different experimental groups and at different post-surgical times. 
Days after ligation (or sham surgery) Sham-saline Sham-NGF 2VO 2VO-saline 2VO-NGF
8 15 10 16 10 18
30 77 5 4 4
75 66 4 3 4
Only eyes showing lack of direct pupillary reflex during the first 24 h were included in the study (see text for further details)BMC Neuroscience 2009, 10:52 http://www.biomedcentral.com/1471-2202/10/52
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istry (123/2004-B), in compliance with the guidelines
published in the National Institute of Health Guidelines for
the Care and Use of Laboratory Animals.
Pupillary reflex
We adopted pupillary reflex procedure described by Ste-
vens et al. [9]. Each animal was first allowed to adapt to
darkness for at least 5 minutes. One eye was then exposed
to a beam of light from an otoscope to assess the direct
reflex response. The otoscope was then immediately
directed at the controlateral eye to assess the consensual
response. Both eyes were then allowed to readapt to dark-
ness for approximately 1 minute. This procedure was then
repeated starting from the controlateral eye. Loss of pupil-
lary reflex is defined as failure of the pupil to constrict
after a 10-second of light exposure. Pupillary reflex was
examined each day for a week after surgery, and at least
once a week until animal sacrifice [9].
Immunohistochemistry
All animals were deeply anesthetized with Ketamine (Ket-
alar, Parke Davis, Italy) 10 mg/kg body weight, i.p. (+
diazepam 2 mg/kg i.m.) and perfused through the ascend-
ing aorta, first with Tyrode-Ca2+ free, pH 6.9 at 37°C (50
ml for adult male rats, 25 ml for young male rats), then
with 4% paraformaldehyde in Sorensen phosphate buffer
0.1 M pH 7 at 37°C (50 ml and 25 ml for adult and young
rats, respectively), finally with the same fixative, at an ice-
cold temperature. During perfusion, animals were bathed
in ice-cold water. The brains were then removed and
immersed for 90 min in the same ice-cold fixative, before
being rinsed for at least 48 h in 5% sucrose in 0.1 M phos-
phate buffer. Retinas were frozen in CO2 and 14 μm thick
coronal sections were then obtained 300 μm from the
optic disk using a cryostat (Kriostat 1750, Leica) and col-
lected on gelatine coated slides. For immunofluorescence
experiments, sections were first incubated in 0.1 M phos-
phate buffered saline (PBS) at room temperature for 10–
30 min, followed by incubation at 4°C for 24 h in a
humid atmosphere with the primary antibodies diluted in
0.3% PBS-Triton X-100, v/v (see Table 2 for the list of
antisera used in this study). After rinsing in PBS for 20 min
(2 × 10 min), the sections were incubated at 37°C for 30
min in a humid atmosphere with the secondary antisera
conjugated with different fluorochromes: Cy™2- conju-
gated affinity-pure Donkey anti-Mouse IgG (H+L), Cy™2-
conjugated affinity-pure Donkey anti-Goat IgG (H+L) and
Rhodamine Red™-X-conjugated affinity-pure Donkey
anti-Rabbit IgG (H+L) (all from Jackson Immunore-
search, West Grove, PA) diluted in PBS triton 0.3%. Sec-
tions were then rinsed in PBS (as above) and mounted in
glycerol containing 1,4-phenylendiamine (0.1 g/l).
Morphometric analysis
Histological and immunohistological images were cap-
tured on a Nikon Eclipse E600 microscope equipped with
a Nikon color digital camera DXm 1200F. Confocal Laser
scanning Microscopy (Olympus IX80 equipped with
FluoView 500 software and 3 laser beam Ar 488, G-HeNe
543, R-HeNe 633 μm) was also used. Measurements were
performed using the Image Pro-Plus software (Media
Cybernetics, MD, USA). The intra-orbital portion of the
optic nerve was analyzed. The diameter of the optic nerve
was measured in 5 sections every 150 μm in the stamp (1
mm) proximal to the optic bulb. The immunoreactive
area was calculated as a fraction (percentage of immuno-
reactive area) of the entire transversal section of the optic
nerve. The thickness of the retina layers was calculated by
dividing each retina, as sampled with coronal sections col-
lected at 300 μm rostral to the optic disk, into 4 quad-
rants. Values are the mean ± SEM in all quadrants. The
number of ganglion cells was estimated along the entire
perimeter of the retina by counting nuclear profiles.
RNA isolation and reverse transcription
Total RNA (total RNA isolation kit, Roche Molecular Bio-
chemicals) was obtained from the inner tunica of the eye
including retina and subjected to DNase treatment (1 U/
μl, Fermentas, Life Sciences, Italy) in the presence of 4 U/
μl RNase inhibitor (4 U/μl, Fermentas), incubating at
37°C for 30 min. First strand cDNAs were obtained after
incubation with 200 U of the M-Moloney murine leukae-
mia virus (M-MuLV) reverse transcriptase enzyme (Fer-
mentas) in a mix reaction composed of 1× First Strand
Buffer, 1 mM of each d(NTP)s (Fermentas) and 5 μM of
the p(dN)6 random primers (Roche Molecular Biochemi-
cals), at 37°C for 50 min, followed by denaturation step
heating at 70°C for 15 min.
Table 2: Primary antisera and working conditions used in the study.
ID Antigens Hosts Suppliers Dilution
betaIII Tubulin betaIII Tubulin Rabbit Santa Cruz 1:300
MBP myelin basic protein Rabbit DAKO 1:100
Mcm-2 mini-chromosome maintenance Goat Santa Cruz 1:150
OX42 OX42 Mouse Serotec 1:300
NG2 NG2 chondroitin sulfate Proteoglycan Mouse Chemicon 1:100
Laminin Laminin Rabbit Sigma 1:25BMC Neuroscience 2009, 10:52 http://www.biomedcentral.com/1471-2202/10/52
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Relative Quantitative real-time PCR
Relative Quantitative real-time PCR reactions were per-
formed in the Mx3005P™ real-time PCR system (Strata-
gene, CA, USA) using SYBR-green I dye. Rat primers for
BAX and Bcl-2, pro- and anti-apoptotic genes, respec-
tively, NGF and its high and low affinity receptors, trk-A
and p75, respectively, VEGF-A and its receptors FLT-1 and
FLK-1 and GAPDH as housekeeping gene, real-time PCR
were designed for SYBR-green chemistry using Beacon
Designer 4.0 software (Premier Biosoft International, Palo
Alto, CA, USA). The sequences of the designed primers as
well as the accession number in the gene bank database
are described in Table 3. For the amplification of NGF, trk-
A, p75, VEGF-A, FLT-1 and GAPDH, the reactions were
performed in a final volume of 25 μl consisting of 1× mas-
ter mix (Brilliant SYBR-green QPCR master mix, Strata-
gene), 16 nM reference dye Rox (Stratagene) and 0.4 μM
forward and reverse primers. Two step PCR reactions (40
cycles of denaturation 95°C for 15 sec, annealing/exten-
sion 60°C for 30 sec) were performed after enzyme activa-
tion (95°C, 10 min); at the end of PCR reaction the
melting curve of amplified products was performed fol-
lowing this temperature/time scheme: heating from 55°C
to 95°C with a temperature increase of 0.5°C/sec. In the
case of FLK-1, the amplification program consisted of 40
cycles of denaturation- 95°C for 15 sec, annealing- 58°C
for 20 sec, extension- 72°C for 20 sec); the melting curve
of amplified products was performed this time starting
from 53°C and following the same temperature/time
scheme.
The relative mRNA level of studied genes was calculated
on the basis of the threshold cycle (CT) values obtained
for each sample. The housekeeping gene GAPDH was
used to normalize the amount of retro-transcribed mRNA
used for PCR reactions. The relative changes in mRNA
expression were examined using the 2-ΔΔCt method [15].
Before processing, the samples corresponding to the dif-
ferent groups of animals, the efficiencies of Bax, Bcl-2, c-
jun, NGF, p75, TrkA, VEGF-A, Flt-1, Flk-1 and GAPDH
real-time PCR reactions were calculated by amplifying
cDNA dilution series in the presence of the corresponding
primers in the conditions described above. Threshold
cycle (CT) values for each pair of primers were used by the
corresponding real-time QPCR instrument software
(Stratagene, CA, USA or BioRad) to calculate standard
curve slopes and efficiencies. For all pairs of primers used
herein we obtained slope and efficiency values that
allowed us to calculate the relative expression of all genes
studied using the formula X = 2-ΔΔCt, where ΔΔCt = average
ΔCt (target gene in a given experimental animal group) -
average ΔCt (target gene in the corresponding control ani-
mal group); ΔCt (target gene of a experimental animal
group) = Ct (target gene) - Ct (GAPDH), for all animals
within this experimental animal group; ΔCt (target gene
of a control animal group) = Ct (target gene) - Ct
(GAPDH), for all animals within this control animal
group.
The specificity of real-time PCR reactions was evidenced
by the melting curve, with a unique peak being obtained
at the corresponding melting temperature (Tm) and by
agarose gel electrophoresis of random PCR products for
Table 3: Sequences of primers used for real-time semiquantitative PCR reactions
Primer Acc. N° Sequence (5'-3') Amplified product (bp)
Bax AF235993 5'-tgctacagggtttcatccag-3' 135
5'-ccagttcatcgccaattcg-3'
Bcl-2 NM_031535 5'-tggaaagcgtagacaaggagatgc-3' 88
5'-caaggctctaggtggtcattcagg-3'
c-jun X17163 5'- aacgaccttctacgacgatg-3' 140
5'-ggtgcggcttcagattgc-3'
NGF M36589 5'- acctcttcggacactctgg-3' 165
5'- cgtggctgtggtcttatctc-3'
P75 NM_012610 5'- agtggcatctctgtggac-3' 130
5'- ctacctcctcacgcttgg-3'
TrkA NM_021589 5'- aagccgtggaacagcatc-3' 91
5'- agcacagagccgttgaag-3'
VEGF AY702972 5'-accctggctttactgctgtac-3' 103
5'- cgtccatgaacttcaccacttc-3'
FLT-1 NM_019306 5'- tgtcctcaactgcaccgtcac-3' 100
5'- ccgctgcctgatagatgctctc-3'
FLK-1 NM_013062 5'- tggcaaatacaacccttcag-3' 108
5'- cacactcagtcaccaacac-3'
GAPDH M17701 5'-ggcaagttcaatggcacagtcaag-3' 125
5'-acatactcagcaccagcatcacc-3'BMC Neuroscience 2009, 10:52 http://www.biomedcentral.com/1471-2202/10/52
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each pair of primers used, obtaining a single band of the
expected size.
Statistical analyses
Graph preparation and statistical analyses were per-
formed using GraphPad Prism 4.0 software. For real-time
PCR experiments from 4 to 6 animals per group were used
and experiments were performed in triplicate. Data are
presented as mean values ± S.E.M. Statistical analyses: 1
way ANOVA and post-hoc Tukey's test were used to com-
pare different experimental groups or else Student's t test,
when only two groups were compared (see legends to the
figures for further details).
Results
Animals
The bilateral permanent occlusion of the carotid arteries
induces the loss of the pupillary reflex within 24 h after
ligation in 62% of the animals included in the study. This
is a permanent deficit, as defined by observation at 8, 30
and 75 days after 2VO. In order to make the experimental
groups more homogeneous, only animals with direct
bilateral or unilateral pupillary reflex loss within this post-
surgical time were included in the study. In the case of
unilateral lesions, only the lesioned eye was considered.
Table 1 reports the number of eyes included in the study
in the different experimental groups. NGF intravitreal
administration performed 24 h after 2VO ligation failed
to induce any functional recovery, as evaluated by pupil-
lary reflex.
Retinal and optic nerve degeneration in 2VO
Permanent bilateral occlusion of the common carotid
arteries causes a degeneration of the retina and optic
nerve, as shown by the histopathology of 2VO versus
sham-operated rat (control) (Fig. 1). In 2VO animals, the
OPL of the retina almost completely disappears 8 days
after ligation, and a reduction of IPL and GCL is also
observed (Fig. 2A). The estimated number of ganglion
cells in the whole perimeter of the retina decreases 75 days
A, B: Histological staining (Hematoxylin-Eosin) of the retina of sham-operated (A) and 2VO ligated 8 days after surgery (B) Figure 1
A, B: Histological staining (Hematoxylin-Eosin) of the retina of sham-operated (A) and 2VO ligated 8 days 
after surgery (B). C, D: Histological staining (Masson Trichromic staining) of the optic nerve of sham (C) and 2VO animals 8 
days after surgery (D). E-R: Optic nerve staining of sham- (E-L) and 2VO- operated animals 8 days after surgery (M-R) with the 
markers listed in the figure. Images are obtained by conventional fluorescence microscopy. Bars: 100 μm (A, B); 200 μm (C-R). 
Abbreviations: ONL: outer nuclear layer; OPL: outer plexiform layer; INL: inner nuclear layer; IPL: inner plexiform layer;GCL: gan-
glion cell layer.BMC Neuroscience 2009, 10:52 http://www.biomedcentral.com/1471-2202/10/52
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after 2VO ligation (Fig. 2B). Atrophy of the optic nerve, as
assessed by nerve diameter, is observed 30 and 75 days
after surgery (Fig. 2C). In order to monitor anatomical
and molecular changes induced by the vascular defect in
the optic nerve, we analysed beta-tubulin as marker for
microtubules, MBP as marker for myelin, laminin as
marker for vascular bed and scar formation, MCM2 as
marker for proliferating cells, OX42 as marker for acti-
vated microglia and NG2 as marker for oligodendrocyte
precursor cells (OPCs). Sample images of the indicated
immunohistochemical staining in control sham operated
and 2VO ligated animals at 8 days after surgery are shown
in Fig 1. We observed a rapid degeneration of axonal
integrity starting from the central portion of the nerve, as
indicated by the decrease in beta-tubulin and MBP immu-
nostaining, which is linked to an increase in the vascular
bed, as depicted by laminin-IR. We also found an impres-
sive increase in cell proliferation, which might be referred
to glial cells including microglia (OX42-IR) and oli-
godendrocyte precursor cells (OPCs) (NG2-IR). We then
Morphometric analysis of the retina and optic nerve in the experimental groups Figure 2
Morphometric analysis of the retina and optic nerve in the experimental groups. In the retina, the OPL layer 
almost disappears in 2VO animal 8 days after surgery (A; Student-t test: ***p < 0.0001). A reduction in the number of ganglion 
cells 75 days after surgery was also found (B, Student's t test: *p < 0.05). The atrophic effect of ligation is shown as reduction of 
the optic nerve diameter (C; one-way ANOVA and post hoc Tukey's test: ##p < 0.001). The semiquantitative analysis of rela-
tive immunoreactive area for the betaIII-Tubulin (D) shows a strong reduction at 8, 30 and 75 days after ligation (one-way 
ANOVA and post hoc Tukey's test: #p < 0.05, ##p < 0.001), such as the analysis of MBP (E, one-way ANOVA and post hoc 
Tukey's test: #p < 0.05; ##p < 0.001). Abbreviations: ONL: outer nuclear layer; OPL: outer plexiform layer; INL: inner nuclear 
layer; IPL: inner plexiform layer;GCL: ganglion cell layer.BMC Neuroscience 2009, 10:52 http://www.biomedcentral.com/1471-2202/10/52
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used beta-tubulin and MBP as markers for axon analysis,
and the graphs in Fig. 2 report the evaluation of immuno-
reactive areas for these antigens, showing a rather rapid
microtubule disaggregation leading to an almost com-
plete depletion of beta-tubulin in the atrophic nerve (75
days) (Fig. 2D). Immunostaining for the myelin sheet
associated with MBP protein decreases more slowly, again
starting from the core of the nerve (Fig. 2E).
NGF administration and retinal and optic nerve 
degeneration
After characterization of the time-course of the retinal and
optic nerve pathology after 2VO ligation, we explored the
possible protective effect of a single NGF intravitreal injec-
tion. We chose to inject NGF 24 hours after 2VO ligation
for two main reasons. The first was technical in nature:
pupillary reflex loss, which was established as an inclu-
sion criteria for the study could develop until 24 hours
after ligation [9]. The second was related to the specific
aim of the study: we intended to evaluate if NGF is able to
interfere with a degeneration process already under way.
In this part of the study, we compared 5 experimental
groups: sham operated animals, sham operated animals
which were intravitreally injected with saline or NGF;
2VO animals which were intravitrealy injected with saline
or NGF; and 2VO animals with intact eyes. In order to
allow NGF diffusion in the humor vitreo, we used an
injection volume of 3 μl, which displayed regular repro-
ducibility with minimum loss of injected solution [13]
and induced an increase in vitreous humor volume of
about 5% [14]. We evaluated the NGF effect on optic
nerve and retina degeneration by estimating the number
of ganglion cells 75 days after 2VO legation, and by meas-
uring the optic nerve diameter, and the beta-tubulin- and
MBP-immunostained area fraction over the optic nerve
transverse section. The data are presented in Fig 3. A sig-
nificant preservation of optic nerve diameter and gangli-
onic cells with nuclear profile is observed in 2VO-NGF-
compared to 2VO-saline-treated rats. This effect is linked
to a positive effect on MBP-, but not beta-tubulin immu-
nostaining.
In order to explore whether the protective effect of NGF
on retinal ganglion cells degeneration induced by
ischemic insult is related to an anti-apoptotic effect of
NGF, we investigated the expression profile of genes
involved in apoptosis, e.g. Bax/Bcl-2 and c-jun by real-
time PCR, 8 days after ligation (Fig. 4). Data are expressed
as relative gene expression in folds of control group
(sham-saline). In the 2VO group, the expression of pro-
apoptotic gene Bax increases in saline-injected, but not in
NGF-injected animals (Fig. 4C), while an increase in the
anti-apoptotic gene Bcl-2 mRNA is observed in this group
(Fig. 4A). Interestingly, Bax up-regulation is observed in
animals having undergone double surgical manipulation,
e.g. vascular ligation and intravitreal injection (2VO-
saline compared with sham-saline) (Fig. 4B). The same
effect by both vascular and mechanical lesions was also
observed in the expression of the immediately early gene
(IEG) c-jun mRNA at the same time-point (Fig. 4D). NGF
counteracted the increase in the expression of c-jun mRNA
in 2VO group of animals (2VO-NGF compared with 2VO-
saline) (Fig. 4E). The expression profile of c-jun  is the
same as that observed for Bax.
Since ocular tissues actively synthesize NGF, we then ana-
lyzed endogenous NGF and related receptor mRNA
expression in the inner tunica including the retina. Since
intraocular production of NGF is strongly regulated by
lesions, such as intravitreal injection and vascular defects,
we utilized as reference group sham-operated animals in
this group of experiments, in which non intravitreal injec-
tions were performed. In all experimental groups we
found an increase in NGF mRNA expression (Fig 5A). In
particular, both mechanical and vascular lesions promote
the expression of NGF mRNA (Fig. 5B,D), and double
lesions (intravitreal injection plus vascular defect) further
increase it (Fig. 5E). When NGF was administered in 2VO-
animals, the local production of NGF mRNA increased
more than 10 fold compared with sham operated animals
but the increase remained statistically significant com-
pared with 2VO saline-injected animals.
The expression of TrkA mRNA is strongly downregulated
by injection and vascular lesions, whereas vascular lesions
increase p75 expression and this effect is not regulated by
NGF administration (Fig. 5G, F).
The mRNA expression of the angiogenic factor VEGF
increases in the retina of 2VO compared to sham-operated
animals 8 days after ligation. In particular vascular lesions
promote expression of VEGF mRNA (Fig. 6B) whereas
mechanical lesion-induced increase is not statistically sig-
nificant (Fig. 6D). Double lesion (intravitreal injection
plus vascular defect) further increases VEGF mRNA
expression level (Fig. 6E). When NGF was administered in
2VO-animals this synergic effect was not detected (Fig.
6C).
The expression of FLK-1 mRNA is strongly down-regu-
lated by injection and vascular lesion (Fig. 6G). Vascular
lesion increases FLT-1 mRNA expression and double
lesions further increase it; this effect is reversed by NGF
administration (Fig. 6F).
Discussion
Permanent bilateral occlusion of the common carotid
arteries is a model of chronic cerebral hypoperfusion lead-
ing to a progressive loss of hippocampal neurons, cholin-BMC Neuroscience 2009, 10:52 http://www.biomedcentral.com/1471-2202/10/52
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ergic dysfunction and cognitive impairment. It also affects
the retina and optic nerve, thus providing a useful model
for investigating the mechanisms of and therapy for the
retinal degeneration associated with vascular defects [9].
In this study we demonstrated that a single intravitreal
injection of NGF has a protective effect on retina and optic
nerve degeneration involving the early regulation of pro-
and anti-apoptotic gene expression. Exogenous NGF
seems to strengthen the effect of endogenous NGF, the
synthesis of which is increased by vascular defect and also
by the mechanical lesion associated with NGF or even
vehicle intraocular delivery.
Animals and model characterization
Permanent bilateral ligation of the carotid arteries causes
rapid optic nerve lesion and loss of the pupillary reflex,
Morphometric analysis of NGF effect on optic nerve diameter (A), ganglion cells (B), betaIII-Tubulin (C) and MBP (D) immu- nostaining Figure 3
Morphometric analysis of NGF effect on optic nerve diameter (A), ganglion cells (B), betaIII-Tubulin (C) and 
MBP (D) immunostaining. NGF administration partially prevents 2VO-induced optic nerve atrophy (A) and ganglion cells 
degeneration at 75 days after surgery. NGF also induces a partially recovery of MBP- immunoreactivity (D), whereas betaIII-
tubuline immunostaining is not modified (C). Statistical analysis: one-way ANOVA and post hoc Tukey's test: #p < 0.05; ##p < 
0.01 and Student-t test: *p < 0.05.).BMC Neuroscience 2009, 10:52 http://www.biomedcentral.com/1471-2202/10/52
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Real time PCR of Bax, Bcl-2 and c-jun genes Figure 4
Real time PCR of Bax, Bcl-2 and c-jun genes. The induction of hypoperfusion induces an increase in the pro-apoptotic 
gene Bax mRNA level (2VO-saline versus sham-saline) in the retina (B) which then decreases after NGF treatment. The relative 
expression of the anti-apoptotic gene Bcl-2 conversely increases in the 2VO-NGF group compared with the sham-saline group 
of animals (A). The vascular lesion also causes the induction of c-jun mRNA expression (2VO-saline versus sham-saline) (D), 
which is counteracted by NGF intravitreal injection (E). Experiments were performed in triplicate. Results are presented as 
mean values ± SEM. Statistical analyses performed: one-way ANOVA with multiple comparison post hoc Tukey's test (#p < 
0.05) and Student's t test (*p < 0.05; **p < 0.01).BMC Neuroscience 2009, 10:52 http://www.biomedcentral.com/1471-2202/10/52
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Relative mRNA expression of NGF and its receptors p75 and TrkA in the retina at 8 days after vessel ligation Figure 5
Relative mRNA expression of NGF and its receptors p75 and TrkA in the retina at 8 days after vessel ligation. 
NGF mRNA increased in all the experimental groups when compared with the sham-operated group of animals (A) and also in 
the 2VO-NGF group when compared with 2VO-saline (NGF effect on vascular lesion) (C). The opposite effect was found for 
the high affinity NGF receptor, TrKA, with a decrease observed in the mRNA level in all the experimental groups compared 
with the sham-operated group of animals (G). The mRNA level of the low affinity NGF receptor p75 is not significantly altered 
in the experimental groups studied except in the case of NGF injected sham group of animals (F). Results are presented as 
mean values ± SEM of experiments performed in duplicate. Statistical analysis was performed by one-way ANOVA and post 
hoc Tukey's multiple comparison test (#p < 0.05; ###p < 0.001) or Student's t test (*p < 0.05).BMC Neuroscience 2009, 10:52 http://www.biomedcentral.com/1471-2202/10/52
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followed by retrograde dysfunction and apoptosis of
RGCs [9,16]. Only a subset of 2VO rats (60%) loses the
pupillary reflex and suffers visual system pathology. This
is probably due to the high individual variability of the
Willis circle structure, which allows reverse perfusion of
the retina through internal carotid and thence pterygopal-
atine arteries that branches from the internal carotid and
supplies blood to the optic nerve [17,8]. Rats without this
characteristic may suffer more severe ischemia and lose
their pupillary reflex [8,17,9]. We included only affected
eyes in our study. Moreover, we analyzed the retina and
the intra-orbital portion of the optic nerve, that is, areas
both supplied by the central artery of the retina, which
derives from of the internal carotid through the ophthal-
mic artery [18,19].
According to the hallmarks of the model [20,10] retinal
degeneration is characterized by a severe reduction of ret-
inal layer thickness, particularly in the OPL and IPL layers,
already 8 days after 2VO, whereas the number of RGC
Relative mRNA expression of VEGF-A, Flt-1 and Flk-1 in the retina at 8 days after vessel ligation Figure 6
Relative mRNA expression of VEGF-A, Flt-1 and Flk-1 in the retina at 8 days after vessel ligation. The relative 
expression of VEGF (A) and its Flt-1 receptor (F) is increased in the 2VO groups with respect to the sham group of animals 
while the relative expression of Flk-1 decreases in 2VO groups compared with sham-group (G). NGF injection reduced the 
damage-induced VEGF mRNA expression. Results were considered statistically significant when one-way ANOVA and post 
hoc Tukey's test, # p < 0.01, ### p < 0.001; Student's t test: *p < 0.05.BMC Neuroscience 2009, 10:52 http://www.biomedcentral.com/1471-2202/10/52
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nuclear profiles decreases 75 days after ligation. The
marked disaggregation of microtubules and myelin disin-
tegration in the optic nerve is accompanied by microglial
activation [16,21,22]. Degeneration of the optic nerve fib-
ers accompanies the progressive death of RGCs.
In our experimental conditions, two pathogenic events
might influence degeneration of RGCs: the first one is
direct retina and optic nerve injury caused by a vascular
defect (hypoperfusion); the second one is eye puncture
and/or injection. In fact, according to Sobrado-Calvo et al.
[22], eye puncture itself or the increase in intraocular pres-
sure due to injection of substances can induce eye dam-
age. An increase in vitreous humor volume of about 5%
[14] induced by an injection volume of 3 μl could contrib-
ute to retinal degeneration. Optic nerve fibers could be
compressed by high intraocular pressure, producing a dis-
ruption of retrograde transport of neurotrophins from the
superior colliculus, along the optic nerve, to the RGC
soma [23,24,3,26]. We actually found an increase in NGF
mRNA expression 8 days after 2VO ligation. At this time,
a rapid and transient activation of OPCs (NG2-IR cells)
and microglial cells is observed in the optic nerve, proba-
bly reflecting inflammation [27].
NGF protects retina and optic nerve from vascular lesion
NGF is a potent stimulant of the trophism and wound
healing process in the eye [28] and basically all eye struc-
tures are able to produce NGF and even to up-regulate
NGF synthesis in the case of lesion [3]. In our study we
found that NGF-injection, but also vehicle injection,
strongly stimulates NGF synthesis in the retina, thus con-
firming that endogenous NGF plays a critical role in retina
and optic nerve protection, also in vascular lesion. More-
over, this increase, observed after 8 days, is further stimu-
lated by hypoperfusion and even more by exogenous
NGF. NGF injected intravitrealy has a great capability to
diffuse and to reach the optic nerve itself [29], as also indi-
cated by the brain diffusion of NGF corneal drops [30]. A
single NGF injection induced the regulation of Bax/Bcl-2
gene expression balance and also the expression of the
IEG c-jun in the retina at the earlier time studied (8 days
after 2VO ligation), and the effect of this single dose of
NGF was long lasting, as indicated by preservation of the
optic nerve diameter and myelination and by RGC profile
counting.
There are several possible stages at which NGF could inter-
fere with retinal and optic nerve degeneration and differ-
ent cellular targets, including: direct effect on RGC
degeneration, indirect effect on RGC retrograde degenera-
tion through axon protection, myelin repair promotion,
neoangiogenesis and vasculogenesis promotion.
NGF counteracts RGC degeneration by affecting Bax/Bcl2
balance- and c-jun- expression, suggesting a direct effect of
NGF on retinal cells. This effect is early and long-lasting.
Axotomy and glaucoma cause apoptosis of RGCs, as has
been demonstrated by expression studies of caspases, Bcl-
2/Bax and c-jun [31-33]. RGC death begins 3 days after
axonal lesion and is preceded by an early activation of Bax
[32]. Moreover, vascular injury also increases the expres-
sion of stress-related proteins, including death-shock pro-
teins as c-fos and DNA nuclear fragmentation in the retina
[34]. In these conditions, neurotrophins support survival
of injured RGCs [12,29,22]. A similar anti-apoptotic effect
of exogenous NGF has also been described in experimen-
tal retinal detachment [35,29].
NGF could also regulate demyelination/remyelination
balance after ischemic injury in the optic nerve, as indi-
cated by the MBP expression regulation. At low concentra-
tions, NGF enhances survival of the oligodendrocyte, the
myelinating and remyelinating cell of the optic nerve [36],
favouring fiber regeneration and proliferation [37] while
at high concentrations it elicits apoptosis of mature corti-
cal oligodendrocytes in vitro [38]. NGF stimulates oli-
godendrocyte differentiation, as defined by the elevation
of myelin basic protein (MBP) in postmitotic cells [39].
NGF also regulates axonal signals that control myelina-
tion, promoting myelination by Schwann cells but reduc-
ing myelination by oligodendrocytes [40,41]. Finally,
hypomyelination of the optic nerve has been observed in
mice lacking BDNF [42,25]. In sum, the picture of the pos-
sible involvement of neurotrophins and related receptors
in myelination is still partial and in some instances, con-
troversial [43].
NGF has also been indicated as a novel angiogenic mole-
cule that may contribute to the maintenance, survival, and
function of endothelial cells by autocrine and/or para-
crine mechanisms [44,45] and the reciprocal regulation
between VEGF and NGF might also result in neuroprotec-
tion [46]. As expected, VEGF and Flt-1 mRNA expression
is up-regulated in 2VO animals, whereas NGF administra-
tion is ineffective in this lesion-induced regulation. How-
ever, time course experiments are to be recommended in
order to explore possible cross talk between NGF and
VEGF signalling.
We also explored NGF high (TrkA) and low (p75NTR)
affinity receptor mRNA expression regulation, observing a
decrease in TrkA expression in all groups compared to the
sham-operated group (the only one without any eye dam-
age), and a slight decrease in p75NTR mRNA expression
in NGF-injected eyes. No up-regulation of p75NTR mRNA
expression was observed in 2VO animals. We studied NGF
receptor expression at only one time-point, and might
thus have missed earlier and late expression regulation. InBMC Neuroscience 2009, 10:52 http://www.biomedcentral.com/1471-2202/10/52
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fact, p75 NTR mRNA expression increases in retina during
experimental glaucoma starting at 20 days, corresponding
to increased Bcl-2/Bax ratio and apoptotic cell death [47].
Indeed, the contribution of the NGF/TrkA/p75NTRp75
signalling pathways to cellular activities is complex and
still largely unknown [48,2,49]. NGF also plays a crucial
role also during nerve injury and in the regulation of
immune and inflammatory responses [49]. According to
this, the expression regulation of NGF receptors is a dis-
tant reflexion of possible cellular action by NGF. P75NTR
is normally scarcely expressed in the retina, and its expres-
sion is differentially regulated also according to the chro-
nology of the lesion. For example, p75 expression
increases 3–5 days after ischemia, and then decreases fur-
ther [50]. Conversely, ocular hypertension induces a late
increase in p75 expression in the retina, i.e. after 28 days
[25] and apoptosis is associated with a consistent p75
expression [3,51].
Conclusion
In this study we showed that a single intra-vitreal NGF
injection protects retina and optic nerve from degenera-
tion due to vascular injury. This effect is also mediated by
an increased synthesis of endogenous NGF due to the
mechanical lesion associated with intraocular delivery.
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